Latest Headlines

Latest Headlines

PaxVax expands commercial network for typhoid vaccine

PaxVax's typhoid vaccine, Vivotif, is licensed for sale in 27 countries. But the Redwood, CA-based company is looking to expand its presence, announcing on Wednesday a series of commercial partnerships and distribution agreements to ensure availability of Vivotif in Australia and Europe.

PaxVax ready to strike M&A; deals that prove its sales model, CEO says

PaxVax entered the M&A; arena last summer, nabbing typhoid vaccine Vivotif from Johnson & Johnson subsidiary Crucell. And it's not stopping there, CEO Ken Kelley says.